Johannes Huber (J Huber)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 25

Top Topics

Prostate Cancer

Urinary Incontinence

Advance Care Planning

Cross Sectional

Top Venues

Current oncology (Toronto, Ont.)

Aktuelle Urologie

World journal of urology

International urology and nephrology

This page only lists publications with an associated author ORCID identifier.

Publications

Christian Volberg, Fabian Urhahn, Anna J Pedrosa Carrasco, Astrid Morin, Martin Gschnell, Johannes Huber, Luka Flegar, Hendrik Heers
End-of-Life Care Preferences of Patients with Advanced Urological Malignancies: An Explorative Survey Study at a Tertiary Referral Center. Current oncology (Toronto, Ont.) 31 (1) (2024)
Christian Volberg, Fabian Urhahn, Anna J Pedrosa Carrasco, Astrid Morin, Martin Gschnell, Johannes Huber, Luka Flegar, Hendrik Heers
End-of-Life Care Preferences of Patients with Advanced Urological Malignancies: An Explorative Survey Study at a Tertiary Referral Center. Current oncology (Toronto, Ont.) 31 (1) (2024)
Christian Volberg, Fabian Urhahn, Anna J Pedrosa Carrasco, Astrid Morin, Martin Gschnell, Johannes Huber, Luka Flegar, Hendrik Heers
End-of-Life Care Preferences of Patients with Advanced Urological Malignancies: An Explorative Survey Study at a Tertiary Referral Center. Current oncology (Toronto, Ont.) 31 (1) (2024)
Christian Volberg, Fabian Urhahn, Anna J Pedrosa Carrasco, Astrid Morin, Martin Gschnell, Johannes Huber, Luka Flegar, Hendrik Heers
End-of-Life Care Preferences of Patients with Advanced Urological Malignancies: An Explorative Survey Study at a Tertiary Referral Center. Current oncology (Toronto, Ont.) 31 (1) (2024)
Christian Volberg, Fabian Urhahn, Anna J Pedrosa Carrasco, Astrid Morin, Martin Gschnell, Johannes Huber, Luka Flegar, Hendrik Heers
End-of-Life Care Preferences of Patients with Advanced Urological Malignancies: An Explorative Survey Study at a Tertiary Referral Center. Current oncology (Toronto, Ont.) 31 (1) (2024)
Smita George Thoduka, Luka Flegar, Christer Groeben, Johannes Huber, Nicole Eisenmenger, Tobias Paulus, Katharina Vogt, Markus Luster, Nasreddin Abolmaali
Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and Liver Metastasis: A Total Population Analysis from 2006 to 2021 in Germany. Current oncology (Toronto, Ont.) 30 (12) (2023)
Smita George Thoduka, Luka Flegar, Christer Groeben, Johannes Huber, Nicole Eisenmenger, Tobias Paulus, Katharina Vogt, Markus Luster, Nasreddin Abolmaali
Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and Liver Metastasis: A Total Population Analysis from 2006 to 2021 in Germany. Current oncology (Toronto, Ont.) 30 (12) (2023)
Benedikt Hoeh, Cristina Cano Garcia, Severine Banek, Niklas Klümper, Alexander Cox, Joerg Ellinger, Philipp Schmucker, Oliver Hahn, Angelika Mattigk, Friedemann Zengerling, Philippe Becker, Kati Erdmann, Bjoern Thorben Buerk, Luka Flegar, Johannes Huber, Charis Kalogirou, Philip Zeuschner
Early CRP kinetics to predict long-term efficacy of first-line immune-checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real-world experience applying different CRP kinetics definitions. Clinical & translational immunology 12 (10) (2023)
Smita George Thoduka, Luka Flegar, Christer Groeben, Johannes Huber, Nicole Eisenmenger, Tobias Paulus, Katharina Vogt, Markus Luster, Nasreddin Abolmaali
Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and Liver Metastasis: A Total Population Analysis from 2006 to 2021 in Germany. Current oncology (Toronto, Ont.) 30 (12) (2023)
Andreas Ihrig, Pascal Marino Pernt, Stefanie Zschäbitz, Johannes Huber, Hans Christoph Friederich, Till Johannes Bugaj, Imad Maatouk
Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer. International urology and nephrology (2023)
Andreas Ihrig, Pascal Marino Pernt, Stefanie Zschäbitz, Johannes Huber, Hans Christoph Friederich, Till Johannes Bugaj, Imad Maatouk
Response to the letter to editor: Neurocognitive deficits attributed to androgen deprivation therapy in patients with prostate cancer should be reconsidered. International urology and nephrology (2023)
Smita George Thoduka, Luka Flegar, Christer Groeben, Johannes Huber, Nicole Eisenmenger, Tobias Paulus, Katharina Vogt, Markus Luster, Nasreddin Abolmaali
Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and Liver Metastasis: A Total Population Analysis from 2006 to 2021 in Germany. Current oncology (Toronto, Ont.) 30 (12) (2023)
Klaus Kraywinkel, Luka Flegar, Johannes Huber, Christer Groeben
[Cancer registries in Germany: what does the future hold for urology?] Aktuelle Urologie (2023)
Smita George Thoduka, Luka Flegar, Christer Groeben, Johannes Huber, Nicole Eisenmenger, Tobias Paulus, Katharina Vogt, Markus Luster, Nasreddin Abolmaali
Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and Liver Metastasis: A Total Population Analysis from 2006 to 2021 in Germany. Current oncology (Toronto, Ont.) 30 (12) (2023)
Christian Doehn, Johannes Huber, Jörg Klier
Aktuelle Urologie 54 (3) (2023)
Till Johannes Bugaj, Imad Maatouk, Tobias Hanslmeier, Stefanie Zschäbitz, Johannes Huber, Charlotte Flock, Hans Christoph Friederich, Andreas Ihrig
Couples coping with advanced prostate cancer: an explorative study on decision-making preferences, self-efficacy and fear of progression. World journal of urology (2023)
Johannes Huber, Hendrik Borgmann, Kurt Miller, Axel S Merseburger, Susanne Krege, Christian Gratzke
[Urology 2030: Why it is key to promote digitisation in urology today to maintain medical care in the future - an expert consensus]. Aktuelle Urologie 54 (3) (2023)
Bastian Keck, Angelika Borkowetz, Julia Poellmann, Thilo Jansen, Moritz Fischer, Susanne Fuessel, Andreas Kahlmeyer, Manfred Wirth, Johannes Huber, Alexander Cavallaro, Matthias Hammon, Ivan Platzek, Arndt Hartmann, Gustavo Baretton, Frank Kunath, Danijel Sikic, Helge Taubert, Bernd Wullich, Kati Erdmann, Sven Wach
Serum miRNAs Support the Indication for MRI-Ultrasound Fusion-Guided Biopsy of the Prostate in Patients with Low-PI-RADS Lesions. Cells 10 (6) (2021)
Martin Baunacke, Maria-Luisa Schmidt, Christer Groeben, Angelika Borkowetz, Christian Thomas, Rainer Koch, Falk Hoffmann, Felix K H Chun, Lothar Weissbach, Johannes Huber
Treatment of post-prostatectomy urinary incontinence and erectile dysfunction: there is insufficient utilisation of care in German cancer survivors. World journal of urology 39 (8) (2020)
Martin Baunacke, Maria-Luisa Schmidt, Christian Thomas, Christer Groeben, Angelika Borkowetz, Rainer Koch, Felix Kh Chun, Lothar Weissbach, Johannes Huber
Long-term functional outcomes after robotic vs. retropubic radical prostatectomy in routine care: a 6-year follow-up of a large German health services research study. World journal of urology 38 (7) (2019)
Luka Flegar, Christer Groeben, Rainer Koch, Martin Baunacke, Angelika Borkowetz, Klaus Kraywinkel, Christian Thomas, Johannes Huber
Trends in Renal Tumor Surgery in the United States and Germany Between 2006 and 2014: Organ Preservation Rate Is Improving. Annals of surgical oncology 27 (6) (2019)
Andreas Ihrig, Theresa Renner, Tanja Muck, Philipp Maatz, Angelika Borkowetz, Bastian Keck, Imad Maatouk, Manfred P Wirth, Johannes Huber
Online support groups offer low-threshold backing for family and friends of patients with prostate cancer. European journal of cancer care 28 (2) (2018)
Johannes Huber, Tanja Muck, Philipp Maatz, Bastian Keck, Paul Enders, Imad Maatouk, Andreas Ihrig
Face-to-face vs. online peer support groups for prostate cancer: A cross-sectional comparison study. Journal of cancer survivorship : research and practice 12 (1) (2017)
B Hager, K Kraywinkel, B Keck, A Katalinic, M Meyer, S R Zeissig, R Scheufele, M P Wirth, Johannes Huber
Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study. Prostate cancer and prostatic diseases 20 (1) (2016)
Johannes Huber, Jürg C Streuli, Novica Lozankovski, Regina J F Stredele, Peter Moll, Markus Hohenfellner, Christian G Huber, Andreas Ihrig, Tim Peters
The complex interplay of physician, patient, and spouse in preoperative counseling for radical prostatectomy: a comparative mixed-method analysis of 30 videotaped consultations. Psycho-oncology 25 (8) (2015)